Profound Medical Corp.
PROF- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001628808
No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Profound Medical Corp. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 34 | 32 | −2 |
| Shares | 8.47M | 7.73M | −747.0K (−8.8%) |
| Value | $91.7M | $71.7M | −$20.0M (−21.8%) |
New holders (3)
Institutions that held Profound Medical Corp. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 17,453 | $162.1K | 0.00% |
| Tower Research Capital LLC (TRC) | 316 | $3.00K | 0.00% |
| Toronto Dominion Bank | 112 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Profound Medical Corp. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 29,832 | $324.9K |
| Crestwood Advisors Group LLC | 18,500 | $201.5K |
| Sutton Wealth Advisors Inc. | 5,000 | $54.5K |
| UBS Group AG | 2,066 | $22.5K |
| Group One Trading, L.P. | 174 | $1.90K |